♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              444 When Does Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR) Peak after Primary Total Hip Arthroplasty (THA)?

              Author:Alexander Strait, MS  Nancy Parks, MS  Nicholas Olson, BS  Tobenna Nwankwo, MS  William Hamilton, MD,FAAOS  Robert Sershon, MD  

              Event Title:(437-448) VIPER: Adult Reconstruction Hip V Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Hip  

              Event Day:Thursday, March 13  

              451 Bacteriophage Treatment of Chronic Multidrug-Resistant Pseudomonas aeruginosa Periprosthetic Joint Infection

              Author:Andrew Frear, BS  Rekha Arya, PhD  Nadine Sadaka, BS  Jewelia Rempuszewski, BS  Dongzhu Ma, MD, PhD  Dana Parker, BA  James Doub  Kenneth Urish, MD,PhD,FAAOS  

              Event Title:(449-460) VIPER: Adult Reconstruction Knee V Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Thursday, March 13  

              467 Temporal Trends in Postoperative Oral Antibiotic Prophylaxis and Infections for Outpatient Total Hip and Knee Arthroplasty from 2015-2020

              Author:Priya Singh, BA  Jiwoo Park, BA  Avanish Yendluri, BS  Kyle Rako, MD  Brocha Stern, PhD,OTR  Jashvant Poeran, MD,PhD  Darwin Chen, MD,FAAOS  Calin Moucha, MD,FAAOS  Brett Hayden, MD, FAAOS  

              Event Title:(461-472) VIPER: Practice Management/Rehabilitation III Papers  

              Event Type:Paper Presentations  

              Category-Classification:Practice Management/Rehabilitation  

              Event Day:Thursday, March 13  

              502 Revision Total Joint Arthroplasty for Prosthetic Joint Infection at Centers of Excellence Decreases Risk of Complications and Improved Discharge Disposition Despite Further Travel Distance

              Author:Akeem Williams  Nicolas Aycardi, BS  Yunseo Linda Park, BS  Logan Finger, MD  Kenneth Urish, MD,PhD,FAAOS  Michael O'Malley, MD,FAAOS  Brian Klatt, MD,FAAOS  Johannes Plate, MD,PhD,FAAOS  

              Event Title:(497-508) VIPER: Adult Reconstruction Hip VI Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Hip  

              Event Day:Thursday, March 13  

              507 Wear-related Revision Rates Following Total Hip Arthroplasty with Marathon Highly Cross-linked Polyethylene in Patients Younger than 50

              Author:Joseph Barbera, MD  Nancy Parks, MS  Robert Sershon, MD  William Hamilton, MD,FAAOS  Nicholas Olson, BS  C Engh, MD,FAAOS  

              Event Title:(497-508) VIPER: Adult Reconstruction Hip VI Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Hip  

              Event Day:Thursday, March 13